US Highland Inc. (OTC.BB: UHLN.PK) Announces New CEO - John Fitzpatrick
TULSA, Okla. - October 19, 2011 (Investorideas.com Newswire) - US Highland Inc. (OTC.BB: UHLN.PK) announced today that Mr. John Fitzpatrick has accepted the position of Chief Executive Officer and President of US Highland, Inc.
Mr. Fitzpatrick brings extensive management experience and organization skills to US Highland. Mr. Fitzpatrick has over 20 years of senior leadership experience in such companies as Hewlett-Packard, Harley-Davidson and Indian Motorcycle Company. Mr. Fitzpatrick was instrumental in the opening of Harley-Davidson's manufacturing plant in Kansas City and led its assembly organization from 1998 to 2000. Mr. Fitzpatrick left Harley-Davidson to become the Vice President of Strategy at the reformation of Indian Motorcycles in Gilroy, California and was promoted to president and chief executive officer shortly after joining the company.
"John's operational and product launch experience is exactly what US Highland needs. US Highland's Management Team is a perfect fit in terms of company vision and core competency required to deliver on that vision," stated US Highland Chairman Robert Harris.
"I cannot imagine a more exciting opportunity than the one we have at US Highland. We have assembled a world-class management team capable of delivering world-class results for our share holders, customers and partners. We are at the right place at the right time with a management team that has the right stuff," stated US Highland President & CEO John Fitzpatrick
US Highland, Inc. (OTC.BB: UHLN.PK) is a US-based designer and manufacturer of high performance, premium quality powertrains. The Company is also a leading development and engineering partner for leading OEMs around the world. http://ushighland.com.
UHLN Company Contact:
John FitzpatrickCEO (918) 827-5254
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: Investorideas.com has been compensated five thousand to advertise US Highland, Inc and distribute news releases and content on their behalf by a third party IR firm.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
Wednesday, October 19, 2011
Nanotech Stock to Watch: mPhase Technologies, Inc. (OTCBB:XDSL)Trades up 42% on Patent News
POINTROBERTS
- October 19, 2011 - Investorideas.com, a leader in sector research for independent investors issues the following nanotechnology stocks trading alert for mPhase Technologies, Inc. (OTCBB:XDSL). The stock is trading up at 0.0050, up 0.0015 (42.86%) on patent news.
The Company reported today that an independent patent valuation of its technology estimates a minimum valuation of $40 million for its portfolio of patents and intellectual property. The technical study of the Company's intellectual property commenced in June of 2011 and was performed by FIRST PRINCIPALS, INC., a world-class technology appraisal and commercialization firm located in Cleveland, Ohio. The Company will release shortly more details of the report including the positioning of such portfolio with key strategic partners.
About mPhase Technologies, Inc. (OTCBB:XDSL)
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and micro fluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energystocks , biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Learn More about Investorideas.com Nanotech showcase stocks
http://www.investorideas.com/Nanotechnology/
Get the global stock directory of publicly traded nanotech stocks
http://www.investorideas.com/Nanotechnology/Stocks_List.asp
Sign up for the free investor news and hot stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
mPhase Technologies, Inc. (XDSL.OB) is a paid showcase nanotech advertising company on Investorideas.com ( fifteen hundred three months)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411
POINT
The Company reported today that an independent patent valuation of its technology estimates a minimum valuation of $40 million for its portfolio of patents and intellectual property. The technical study of the Company's intellectual property commenced in June of 2011 and was performed by FIRST PRINCIPALS, INC., a world-class technology appraisal and commercialization firm located in Cleveland, Ohio. The Company will release shortly more details of the report including the positioning of such portfolio with key strategic partners.
About mPhase Technologies, Inc. (OTCBB:XDSL)mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and micro fluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy
Learn More about Investorideas.com Nanotech showcase stocks
http://www.investorideas.com/Nanotechnology/
Get the global stock directory of publicly traded nanotech stocks
http://www.investorideas.com/Nanotechnology/Stocks_List.asp
Sign up for the free investor news and hot stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
mPhase Technologies, Inc. (XDSL.OB) is a paid showcase nanotech advertising company on Investorideas.com ( fifteen hundred three months)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411
Nanotechnology Stocks; mPhase (OTC.BB:XDSL) Patents Valued at $40 Million
LITTLE FALLS, NJ - October 19, 2011 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL.OB) reported today that an independent patent valuation of its technology estimates a minimum valuation of $40 million for its portfolio of patents and intellectual property. The technical study of the Company's intellectual property commenced in June of 2011 and was performed by FIRST PRINCIPALS, INC., a world-class technology appraisal and commercialization firm located in Cleveland, Ohio. The Company will release shortly more details of the report including the positioning of such portfolio with key strategic partners.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
LITTLE FALLS, NJ - October 19, 2011 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL.OB) reported today that an independent patent valuation of its technology estimates a minimum valuation of $40 million for its portfolio of patents and intellectual property. The technical study of the Company's intellectual property commenced in June of 2011 and was performed by FIRST PRINCIPALS, INC., a world-class technology appraisal and commercialization firm located in Cleveland, Ohio. The Company will release shortly more details of the report including the positioning of such portfolio with key strategic partners.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Kim Bradford, President and CEO of Osage (OTCBB: OEDV) Discusses the Company's Net Acreage Expansion and How the Mississippian Formation Play is Heating Up
Point Roberts, WA - October 18, 2011- Investorideas.com, a leader in sector research including oil and gas stocks, issues a recent exclusive interview with Kim Bradford, President and CEO of Osage Exploration and Development, Inc. (OTCBB: OEDV) discussing the Company's recent expansion to 15,000 net acres in the Nemaha Ridge, Oklahoma horizontal Mississippian play.
Interview
Q: Investorideas.com
Kim, since the Company announced its joint venture with Slawson Exploration Company, Inc. and U.S. Energy Development Corporation back in May, your net acreage has grown from 10,000 to 15,000 net acres. Can you share with investors how a small company's strategy and approach to purchasing smaller acreage packages can work to your benefit and ultimately the shareholders?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
That is a very good question, the answer has to do with the relative impact an acquisition can make to a given Company. Simply stated, if a very large oil and gas company had acquired 10,000 acres in the horizontal Mississippian play, it would probably be so small relative to their asset base that the acquisition would be virtually meaningless in the investment thesis for that large company. In our case, this acquisition is huge relative to our size, therefore success in this project could propel our equity value and stock price many times their current levels. Keep in mind, for Osage this is probably a five year project of drilling and development with a corresponding five year period of growth in production and reserves. In other words, the performance of Osage is very leveraged to this project, where in another larger company it might not be. Likewise, our ability to continue to expand the project displays a similar characteristic. In the parallel example above, to a large company acquiring an additional 5000 acres would be just as meaningless as the first 10,000 acres. In Osage's case however, this represents a full 50% increase over what we had acquired just a few months earlier, and nearly a 50% growth in the size of the asset base of the Company in a very short time which is extremely significant to our investment thesis.
Q: Investorideas.com
The Mississippian formation play is heating up in terms of new entrants. Recently PetroQuest Energy (NYSE:PQ ) announced they had closed its Mississippian Lime acquisition of 28,250 acres for an adjusted purchase price of $24,100,000. Can you share with investors what you are seeing in terms of growing interest from the majors and why?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
All of the major Oklahoma based publicly traded oil and gas exploration companies have been involved in developing horizontal Mississippian projects. SandRidge Energy, Chesapeake Energy Corporation, Devon Energy Corporation, Range Resources, Continental Resources, as well as many privately owned Oklahoma based companies are involved in the play. PetroQuest joins the growing list of non-Oklahoma based companies acquiring horizontal Mississippian projects. What I believe we are seeing is a similar sort of phenomenon like we have witnessed in the Marcellus shale play, the Haynesville shale play, and others which is that companies feel that they have to be exposed to this play. Strategically, the bigger oil companies cannot afford to miss a domestic opportunity with great economics, unless it is truly outside their area of focus or expertise. It is fair to say that almost every significant oil company in America has access and expertise in the Mid-Continent, so we are seeing a groundswell in the number of companies endorsing the horizontal Mississippian in Oklahoma.
Q: Investorideas.com
Kim in your last press release you said the Company was on track to begin drilling by the end of the year. Can you give investors a short outline of the process?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
Our Operator, Slawson Exploration has direct responsibility for all activities on the ground when it comes to drilling, which is a very good thing for the Osage shareholder. Slawson has drilled thousands of wells in their history and are highly regarded for their efficiency and success rate. In Oklahoma, as in other places, there are many governmental, bureaucratic processes that must be completed before drilling can begin. Those initiatives are well advanced and conform to the time schedule that we have laid out. The rig has been contracted, and there are really no barriers to us to get our wells started this year, we are definitely on target.
Q: Investorideas.com
The Mississippian has a successful vertical history, which has resulted in a superior drilling success rate as horizontal play, with a record of no dry holes. As a junior oil and gas Company, what does that represent in terms of risk/reward potential for investors?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
When I first started investing in oil and gas in the 1970's, a dry hole was probably the most relevant risk, and certainly the one that could cause you to lose all your money quickly. In the horizontal Mississippian play, the formula that all the successful companies are employing virtually guarantees that a dry hole is a highly unlikely outcome. That formula is simply to go to an area that has produced vertically out the Mississippian formation, and then proceed to drill horizontally in that place. When you do that, you are drilling into a formation that you know from the vertical well results is productive. Because historically in Oklahoma the vertical Mississippian wells that have been drilled were not highly fracture stimulated, in many cases not stimulated at all, those vertical wells did not drain the reservoir efficiently. So what we are doing is going into a reservoir that we know produces oil then utilizing horizontal wellbores to increase the amount of exposure to that known productive reservoir, and finally using the most advanced stage fracturing process to maximize recovery from that known-productive reservoir. Given the industry's experience in utilizing these techniques, it is not a surprise that we have not had a single dry hole out of the first 300 horizontal wells drilled in the horizontal Mississippian, nor do we expect any.
Q: Investorideas.com
Based on recent developments and without disclosing anything out of the public domain, can you share with us your strategy for growing the Company over the next year?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
It is fair to say that our focus is on developing our potentially huge Nemaha Ridge Mississippian project in conjunction with our partners, Slawson Exploration and US Energy Development Corporation. That said, we are a grassroots exploration company by choice because that is how we can create the most leverage and highest returns for our shareholders. We will continue to try and develop additional onshore US projects similar to our Nemaha Ridge project which can be truly transformative for our Company.
About Osage Exploration and Development, Inc.
Based in San Diego, California with production offices in Oklahoma City, Oklahoma, and executive offices in Bogotá, Colombia, Osage Exploration and Development, Inc. is an independent exploration and production company with interests in oil and gas wells and prospects in the US and Colombia. www.osageexploration.com
Follow (OTCBB: OEDV) on Twitter.com
http://twitter.com/#!/OsageOEDV
Link to news release: read full news
http://www.investorideas.com/CO/OEDV/news/2011/05272.asp
About Slawson Exploration Company, Inc.
Headquartered in Wichita, KS, with regional offices in Denver, Houston, and Oklahoma City, Slawson was founded in 1957. http://www.slawsoncompanies.com/exploration.html
About U.S. Energy Development Corporation
U.S. Energy Development Corporation was formed in 1980 as a successor to Oilmark & Company, Inc., founded in 1978. The company has consistently been ranked among the Top 50 Independent Oil & Natural Gas Drillers in the United States and is one of the largest drillers in both New York and Pennsylvania. Since 1980, U.S. Energy has acted as operator with respect to the drilling of more than 2,500 wells. www.usenergydevcorp.com
Safe Harbor Statement
The information in this release includes certain forward-looking statements as defined by the Securities and Exchange Commission that are based on assumptions that in the future may prove not to have been accurate. Those statements and Osage Exploration and Development, Inc. are subject to a number of risks, including production variances from expectations, volatility of product prices, inability to raise sufficient capital to fund its operations, environmental risks, competition, government regulation, and the ability of the Company to execute its business strategy, among others.
Contact:
Osage Exploration and Development, Inc.
Kim Bradford , President and CEO
Phone: 619-677-3956
Fax: 619-677-3964
kbradford@osageexploration.com
www.osageexploration.com
Osage Exploration and Development, Inc. (OEDV.OB) is a showcase oil and gas stock on Investorideas.com
Visit the company showcase profile at Investorideas.com
http://www.investorideas.com/CO/OEDV/
Request news and trading alerts on OEDV
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer: Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: OEDV is a paid advertising oil and gas company on Investorideas.com - Disclosure: (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source - Investorideas.com
800-665-0411
Point Roberts, WA - October 18, 2011- Investorideas.com, a leader in sector research including oil and gas stocks, issues a recent exclusive interview with Kim Bradford, President and CEO of Osage Exploration and Development, Inc. (OTCBB: OEDV) discussing the Company's recent expansion to 15,000 net acres in the Nemaha Ridge, Oklahoma horizontal Mississippian play.
Interview
Q: Investorideas.com
Kim, since the Company announced its joint venture with Slawson Exploration Company, Inc. and U.S. Energy Development Corporation back in May, your net acreage has grown from 10,000 to 15,000 net acres. Can you share with investors how a small company's strategy and approach to purchasing smaller acreage packages can work to your benefit and ultimately the shareholders?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
That is a very good question, the answer has to do with the relative impact an acquisition can make to a given Company. Simply stated, if a very large oil and gas company had acquired 10,000 acres in the horizontal Mississippian play, it would probably be so small relative to their asset base that the acquisition would be virtually meaningless in the investment thesis for that large company. In our case, this acquisition is huge relative to our size, therefore success in this project could propel our equity value and stock price many times their current levels. Keep in mind, for Osage this is probably a five year project of drilling and development with a corresponding five year period of growth in production and reserves. In other words, the performance of Osage is very leveraged to this project, where in another larger company it might not be. Likewise, our ability to continue to expand the project displays a similar characteristic. In the parallel example above, to a large company acquiring an additional 5000 acres would be just as meaningless as the first 10,000 acres. In Osage's case however, this represents a full 50% increase over what we had acquired just a few months earlier, and nearly a 50% growth in the size of the asset base of the Company in a very short time which is extremely significant to our investment thesis.
Q: Investorideas.com
The Mississippian formation play is heating up in terms of new entrants. Recently PetroQuest Energy (NYSE:PQ ) announced they had closed its Mississippian Lime acquisition of 28,250 acres for an adjusted purchase price of $24,100,000. Can you share with investors what you are seeing in terms of growing interest from the majors and why?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
All of the major Oklahoma based publicly traded oil and gas exploration companies have been involved in developing horizontal Mississippian projects. SandRidge Energy, Chesapeake Energy Corporation, Devon Energy Corporation, Range Resources, Continental Resources, as well as many privately owned Oklahoma based companies are involved in the play. PetroQuest joins the growing list of non-Oklahoma based companies acquiring horizontal Mississippian projects. What I believe we are seeing is a similar sort of phenomenon like we have witnessed in the Marcellus shale play, the Haynesville shale play, and others which is that companies feel that they have to be exposed to this play. Strategically, the bigger oil companies cannot afford to miss a domestic opportunity with great economics, unless it is truly outside their area of focus or expertise. It is fair to say that almost every significant oil company in America has access and expertise in the Mid-Continent, so we are seeing a groundswell in the number of companies endorsing the horizontal Mississippian in Oklahoma.
Q: Investorideas.com
Kim in your last press release you said the Company was on track to begin drilling by the end of the year. Can you give investors a short outline of the process?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
Our Operator, Slawson Exploration has direct responsibility for all activities on the ground when it comes to drilling, which is a very good thing for the Osage shareholder. Slawson has drilled thousands of wells in their history and are highly regarded for their efficiency and success rate. In Oklahoma, as in other places, there are many governmental, bureaucratic processes that must be completed before drilling can begin. Those initiatives are well advanced and conform to the time schedule that we have laid out. The rig has been contracted, and there are really no barriers to us to get our wells started this year, we are definitely on target.
Q: Investorideas.com
The Mississippian has a successful vertical history, which has resulted in a superior drilling success rate as horizontal play, with a record of no dry holes. As a junior oil and gas Company, what does that represent in terms of risk/reward potential for investors?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
When I first started investing in oil and gas in the 1970's, a dry hole was probably the most relevant risk, and certainly the one that could cause you to lose all your money quickly. In the horizontal Mississippian play, the formula that all the successful companies are employing virtually guarantees that a dry hole is a highly unlikely outcome. That formula is simply to go to an area that has produced vertically out the Mississippian formation, and then proceed to drill horizontally in that place. When you do that, you are drilling into a formation that you know from the vertical well results is productive. Because historically in Oklahoma the vertical Mississippian wells that have been drilled were not highly fracture stimulated, in many cases not stimulated at all, those vertical wells did not drain the reservoir efficiently. So what we are doing is going into a reservoir that we know produces oil then utilizing horizontal wellbores to increase the amount of exposure to that known productive reservoir, and finally using the most advanced stage fracturing process to maximize recovery from that known-productive reservoir. Given the industry's experience in utilizing these techniques, it is not a surprise that we have not had a single dry hole out of the first 300 horizontal wells drilled in the horizontal Mississippian, nor do we expect any.
Q: Investorideas.com
Based on recent developments and without disclosing anything out of the public domain, can you share with us your strategy for growing the Company over the next year?
A: Kim Bradford, President and CEO of Osage Exploration and Development, Inc.
It is fair to say that our focus is on developing our potentially huge Nemaha Ridge Mississippian project in conjunction with our partners, Slawson Exploration and US Energy Development Corporation. That said, we are a grassroots exploration company by choice because that is how we can create the most leverage and highest returns for our shareholders. We will continue to try and develop additional onshore US projects similar to our Nemaha Ridge project which can be truly transformative for our Company.
About Osage Exploration and Development, Inc.
Based in San Diego, California with production offices in Oklahoma City, Oklahoma, and executive offices in Bogotá, Colombia, Osage Exploration and Development, Inc. is an independent exploration and production company with interests in oil and gas wells and prospects in the US and Colombia. www.osageexploration.com
Follow (OTCBB: OEDV) on Twitter.com
http://twitter.com/#!/OsageOEDV
Link to news release: read full news
http://www.investorideas.com/CO/OEDV/news/2011/05272.asp
About Slawson Exploration Company, Inc.
Headquartered in Wichita, KS, with regional offices in Denver, Houston, and Oklahoma City, Slawson was founded in 1957. http://www.slawsoncompanies.com/exploration.html
About U.S. Energy Development Corporation
U.S. Energy Development Corporation was formed in 1980 as a successor to Oilmark & Company, Inc., founded in 1978. The company has consistently been ranked among the Top 50 Independent Oil & Natural Gas Drillers in the United States and is one of the largest drillers in both New York and Pennsylvania. Since 1980, U.S. Energy has acted as operator with respect to the drilling of more than 2,500 wells. www.usenergydevcorp.com
Safe Harbor Statement
The information in this release includes certain forward-looking statements as defined by the Securities and Exchange Commission that are based on assumptions that in the future may prove not to have been accurate. Those statements and Osage Exploration and Development, Inc. are subject to a number of risks, including production variances from expectations, volatility of product prices, inability to raise sufficient capital to fund its operations, environmental risks, competition, government regulation, and the ability of the Company to execute its business strategy, among others.
Contact:
Osage Exploration and Development, Inc.
Kim Bradford , President and CEO
Phone: 619-677-3956
Fax: 619-677-3964
kbradford@osageexploration.com
www.osageexploration.com
Osage Exploration and Development, Inc. (OEDV.OB) is a showcase oil and gas stock on Investorideas.com
Visit the company showcase profile at Investorideas.com
http://www.investorideas.com/CO/OEDV/
Request news and trading alerts on OEDV
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer: Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: OEDV is a paid advertising oil and gas company on Investorideas.com - Disclosure: (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source - Investorideas.com
800-665-0411
Mining and Gold Stocks; YALE (TSX-V: YLL) to Option out Orofino - Six Projects Now under Option
VANCOUVER, British Columbia - October 19, 2011 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL and Frankfurt: YAB) is pleased to report that it has signed and formalized an Option Agreement with Overlord Capital Ltd. � a Capital Pool Company � for Yale's wholly owned Orofino Property located in Sonora State, Mexico. The transaction is intended to be Overlord's "Qualifying Transaction."
Under the terms of the Option Agreement, in order to earn up to a 70% interest in the property, Overlord will be required to pay Yale $100,000, issue to Yale 1,300,000 shares in Overlord, and incur a total of $2,350,000 in exploration expenditures on the Property over a four year period.
Overlord must pay Yale $50,000 and issue 50,000 common shares upon receipt of Venture Exchange approval to the proposed qualifying transaction. Subsequent share issuances of 500,000, 150,000, 350,000 and 250,000 shares on the first, second, third, and fourth year anniversaries will also be due in order to keep the Option Agreement in good standing. The first year's requirement will be $200,000 in exploration expenditures followed by a further $400,000 in the following year, $750,000 in the third year and $1,000,000 in the final year of the Option Agreement. Yale will be the initial operator and will manage exploration on the property.
"With this transaction, Yale continues to prove the merits of its project generator business model. With six projects optioned out, Yale will be extremely busy in the coming months as multiple exploration programs will be running concurrently," stated Ian Foreman, P.Geo., president of Yale.
Tenoriba Property:
The Company would also like to announce that it has dropped the option to earn a 100% interest in the Tenoriba Property located in southwestern Chihuahua State. "Tenoriba had excellent up-side potential, however, due to unpredictable community relations Yale was unable to undertake ongoing exploration in the area and, in turn, attract an optionee for the project," stated Ian Foreman, P.Geo., president of Yale.
About Yale Resources:
Yale Resources utilizes the project generator business model to maximize its exposure to discovery while minimizing shareholder risk. Yale currently has nine projects in its portfolio of which five are optioned out with commitments totalling approximately $1.3 M in expenditures during the next 12 months. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President
For additional information on Yale Resources please call the Company at 604-678-2531.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
Contact:
Yale Resources Ltd.
Ian Foreman
604-678-2531
VANCOUVER, British Columbia - October 19, 2011 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL and Frankfurt: YAB) is pleased to report that it has signed and formalized an Option Agreement with Overlord Capital Ltd. � a Capital Pool Company � for Yale's wholly owned Orofino Property located in Sonora State, Mexico. The transaction is intended to be Overlord's "Qualifying Transaction."
Under the terms of the Option Agreement, in order to earn up to a 70% interest in the property, Overlord will be required to pay Yale $100,000, issue to Yale 1,300,000 shares in Overlord, and incur a total of $2,350,000 in exploration expenditures on the Property over a four year period.
Overlord must pay Yale $50,000 and issue 50,000 common shares upon receipt of Venture Exchange approval to the proposed qualifying transaction. Subsequent share issuances of 500,000, 150,000, 350,000 and 250,000 shares on the first, second, third, and fourth year anniversaries will also be due in order to keep the Option Agreement in good standing. The first year's requirement will be $200,000 in exploration expenditures followed by a further $400,000 in the following year, $750,000 in the third year and $1,000,000 in the final year of the Option Agreement. Yale will be the initial operator and will manage exploration on the property.
"With this transaction, Yale continues to prove the merits of its project generator business model. With six projects optioned out, Yale will be extremely busy in the coming months as multiple exploration programs will be running concurrently," stated Ian Foreman, P.Geo., president of Yale.
Tenoriba Property:
The Company would also like to announce that it has dropped the option to earn a 100% interest in the Tenoriba Property located in southwestern Chihuahua State. "Tenoriba had excellent up-side potential, however, due to unpredictable community relations Yale was unable to undertake ongoing exploration in the area and, in turn, attract an optionee for the project," stated Ian Foreman, P.Geo., president of Yale.
About Yale Resources:
Yale Resources utilizes the project generator business model to maximize its exposure to discovery while minimizing shareholder risk. Yale currently has nine projects in its portfolio of which five are optioned out with commitments totalling approximately $1.3 M in expenditures during the next 12 months. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President
For additional information on Yale Resources please call the Company at 604-678-2531.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
Contact:
Yale Resources Ltd.
Ian Foreman
604-678-2531
Visit the YLL showcase profile at Investorideas.com
Request News and Info on YLL
Disclosure, Disclaimer/ YLL is a paid advertising client on Investorideas.com and our mining portals.
Request News and Info on YLL
Disclosure, Disclaimer/ YLL is a paid advertising client on Investorideas.com and our mining portals.
Tuesday, October 18, 2011
Biotech Stock Alert; (OTC: AEMD) Trading Up 21% on News of Availability of its Exosome Detection Assay
Point Roberts, WA- October 18 , 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, report Aethlon Medical (OTCBB: AEMD), a pioneer in developing therapeutic filtration devices is trading up at 0.08, up 0.0140 (21.21%) in late morning trading on over 450,000 shares.
The Company reported news on the opening that it will begin accepting orders for its Enzyme Linked Lectin Specific Assay (ELLSA™) from researchers that require a highly sensitive diagnostic tool to detect the presence of exosomes in cell culture, ascites, and other biological fluids, including blood.
Biotech Investor Snapshot for Aethlon Medical (OTCBB: AEMD)
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.
Visit the AEMD showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech, biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com
Point Roberts, WA- October 18 , 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, report Aethlon Medical (OTCBB: AEMD), a pioneer in developing therapeutic filtration devices is trading up at 0.08, up 0.0140 (21.21%) in late morning trading on over 450,000 shares.
The Company reported news on the opening that it will begin accepting orders for its Enzyme Linked Lectin Specific Assay (ELLSA™) from researchers that require a highly sensitive diagnostic tool to detect the presence of exosomes in cell culture, ascites, and other biological fluids, including blood.
Biotech Investor Snapshot for Aethlon Medical (OTCBB: AEMD)
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.
Visit the AEMD showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech, biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com
Trending Investor Searches; (NASDAQ:BPAX), (NASDAQ:HEV), (NASDAQ:AONE), (NASDAQ:SZYM) Make Top Four
Water Stocks, Natural Gas Stocks and Renewable Energy Stocks Lead Sectors
POINT ROBERTS, October 18 , 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on this weeks trending top ten investor searches.
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX ) was the most searched by investors in the past week following news from the Company that the independent Data Monitoring Committee (DMC) had completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects. The independent DMC has recommended that the LibiGel safety study should continue as per the FDA-agreed protocol, without modifications. LibiGel (testosterone gel) is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
Leading sectors searched by investors included water stocks, natural gas stocks and renewable energy stocks.
Investorideas.com Top Investor Searches…
1. NASDAQ:BPAX
2. NASDAQ:HEV
3. NASDAQ:AONE
4. NASDAQ:SZYM
5. NASDAQ:TSLA
6. Water Stocks
7. NASDAQ:SINA
8. NASDAQ:TQNT
9. Natural Gas Stocks
10. Renewable Energy Stocks
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investorideas.com Free Investor Tools;
Learn More about Investorideas.com showcase stocks
http://www.investorideas.com/Showcase/
Sign up for the free investor news and stock alerts- water stocks, renewable energy, gold stocks and more
http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Become a Member
Research renewable energy stocks, gold stocks, water stocks, oil and gas and more with the largest stock directories online for investors
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including renewable energy, water and energy stocks. The renewable energy stocks directory features over 1300 green stocks, making it the largest online !
Visit the Investor Ideas membership page to learn more at:
http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. BPAX is a paid showcase stock on Investorideas.com – six thousand five hundred for 3 months
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source – Investorideas.com
800-665-0411
Water Stocks, Natural Gas Stocks and Renewable Energy Stocks Lead Sectors
POINT ROBERTS, October 18 , 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on this weeks trending top ten investor searches.
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX ) was the most searched by investors in the past week following news from the Company that the independent Data Monitoring Committee (DMC) had completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects. The independent DMC has recommended that the LibiGel safety study should continue as per the FDA-agreed protocol, without modifications. LibiGel (testosterone gel) is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
Leading sectors searched by investors included water stocks, natural gas stocks and renewable energy stocks.
Investorideas.com Top Investor Searches…
1. NASDAQ:BPAX
2. NASDAQ:HEV
3. NASDAQ:AONE
4. NASDAQ:SZYM
5. NASDAQ:TSLA
6. Water Stocks
7. NASDAQ:SINA
8. NASDAQ:TQNT
9. Natural Gas Stocks
10. Renewable Energy Stocks
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investorideas.com Free Investor Tools;
Learn More about Investorideas.com showcase stocks
http://www.investorideas.com/Showcase/
Sign up for the free investor news and stock alerts- water stocks, renewable energy, gold stocks and more
http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Become a Member
Research renewable energy stocks, gold stocks, water stocks, oil and gas and more with the largest stock directories online for investors
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including renewable energy, water and energy stocks. The renewable energy stocks directory features over 1300 green stocks, making it the largest online !
Visit the Investor Ideas membership page to learn more at:
http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. BPAX is a paid showcase stock on Investorideas.com – six thousand five hundred for 3 months
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source – Investorideas.com
800-665-0411
Monday's NASDAQ Winners: ANDS, BEXP, SNDA, RMTR
POINT ROBERTS - October 18, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday October 17th. Markets were off once again on Euro woes with Nasdaq closing lower by -52.93 (-1.98%) at 2614.92.
Yes Virginia there is a Santa Clause... Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) was the top percentage gainer for the session closing higher 2.61, a whopping (250.96%) to $3.65 after the company reported it agreed to be acquired by Roche Holding AG for $3.70 a share. Anadys' board has recommended stockholders tender their shares and, if necessary, adopt the merger agreement. This news was of course followed by the usual barrage of law firm announcements questioning the deal for shareholders.
The stock is continuing its gains in morning trading for Tuesday's session.
Brigham Exploration Company (NASDAQ:BEXP) surged 6.39 (21.05%) to close at $6.75 after Statoil ASA said that it has agreed to buy the company for $4.4 billion.
Shana Interactive Entertainment Ltd ADR (NASDAQ:SNDA) closed with an impressive gain of 4.85 (14.49%) to end the day at $38.33 after Chairman Chen Tianqiao said he would buy all outstanding shares to take the company private.
Ramtron International (NASDAQ:RMTR) moved higher by 0.23 (11.68%) to $2.20, bouncing back from its recent low of $1.95. The stock has a 52-week range of $1.87-$4.17. The company has market capitalization of $63.48 million.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas: stock directories and trading alerts, investing ideas
Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
POINT ROBERTS - October 18, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday October 17th. Markets were off once again on Euro woes with Nasdaq closing lower by -52.93 (-1.98%) at 2614.92.
Yes Virginia there is a Santa Clause... Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) was the top percentage gainer for the session closing higher 2.61, a whopping (250.96%) to $3.65 after the company reported it agreed to be acquired by Roche Holding AG for $3.70 a share. Anadys' board has recommended stockholders tender their shares and, if necessary, adopt the merger agreement. This news was of course followed by the usual barrage of law firm announcements questioning the deal for shareholders.
The stock is continuing its gains in morning trading for Tuesday's session.
Brigham Exploration Company (NASDAQ:BEXP) surged 6.39 (21.05%) to close at $6.75 after Statoil ASA said that it has agreed to buy the company for $4.4 billion.
Shana Interactive Entertainment Ltd ADR (NASDAQ:SNDA) closed with an impressive gain of 4.85 (14.49%) to end the day at $38.33 after Chairman Chen Tianqiao said he would buy all outstanding shares to take the company private.
Ramtron International (NASDAQ:RMTR) moved higher by 0.23 (11.68%) to $2.20, bouncing back from its recent low of $1.95. The stock has a 52-week range of $1.87-$4.17. The company has market capitalization of $63.48 million.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas: stock directories and trading alerts, investing ideas
Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
Biotech Stock News; Aethlon Medical (OTCBB: AEMD) Announces Availability of its Exosome Detection Assay to the Research Community
SAN DIEGO � October 18, 2011 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it will begin accepting orders for its Enzyme Linked Lectin Specific Assay (ELLSA™) from researchers that require a highly sensitive diagnostic tool to detect the presence of exosomes in cell culture, ascites, and other biological fluids, including blood.
"We are going to produce ELLSA™ on a limited basis to satisfy the organic demand for our technology, which is primarily being driven by researchers who participated in a beta-testing program," stated Aethlon CEO, Jim Joyce. "However, as our focus is directed toward advancing Aethlon ADAPT™ system therapies, we plan to license or sell ELLSA™ to an organization that is already established in the research diagnostics field." Each ELLSA™ plate allows for up to 96 exosome detection tests. Further analysis of the captured exosomes is possible through detection molecules such as antibodies linked to a specific biomarker on the exosome. ELLSA™ has demonstrated the ability to identify and quantify the presence of exosomes produced by human immunodeficiency virus (HIV), and tuberculosis (TB), as well as all forms of cancer tested to date. The introductory price for each ELLSA order placed by November 30, 2011 is $179.00 per kit. To place an order, contact Paul Duffin at 858-459-7800 x306, or by email at paul@aethlonmedical.com. Aethlon Medical is offering ELLSA™ for research purposes only and not for human use.
About Aethlon Medical
The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT™ system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. Our lead therapeutic candidate is the Aethlon Hemopurifier®, a device with broad-spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes. In human studies, Hemopurifier® therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs. We are now focused on advancing our Hemopurifier® as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens. Based on studies conducted by government and non-government research organizations, the Hemopurifier® is also a leading broad-spectrum treatment candidate to address bioterror and pandemic threats. For more information, please visit www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the ability to demonstrate ex vivo effectiveness of the Aethlon Hemopurifier® to remove immunosuppressive exosomes from the blood of advanced-stage cancer patients, future therapeutic trials in cancer patients, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the Hemopurifier's® ability to capture exosomes and the impact it may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
Jody Cain
Senior Vice President, Lippert/Heilshorn & Associates
310.691.7100
jcain@lhai.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
SAN DIEGO � October 18, 2011 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it will begin accepting orders for its Enzyme Linked Lectin Specific Assay (ELLSA™) from researchers that require a highly sensitive diagnostic tool to detect the presence of exosomes in cell culture, ascites, and other biological fluids, including blood.
"We are going to produce ELLSA™ on a limited basis to satisfy the organic demand for our technology, which is primarily being driven by researchers who participated in a beta-testing program," stated Aethlon CEO, Jim Joyce. "However, as our focus is directed toward advancing Aethlon ADAPT™ system therapies, we plan to license or sell ELLSA™ to an organization that is already established in the research diagnostics field." Each ELLSA™ plate allows for up to 96 exosome detection tests. Further analysis of the captured exosomes is possible through detection molecules such as antibodies linked to a specific biomarker on the exosome. ELLSA™ has demonstrated the ability to identify and quantify the presence of exosomes produced by human immunodeficiency virus (HIV), and tuberculosis (TB), as well as all forms of cancer tested to date. The introductory price for each ELLSA order placed by November 30, 2011 is $179.00 per kit. To place an order, contact Paul Duffin at 858-459-7800 x306, or by email at paul@aethlonmedical.com. Aethlon Medical is offering ELLSA™ for research purposes only and not for human use.
About Aethlon Medical
The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT™ system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. Our lead therapeutic candidate is the Aethlon Hemopurifier®, a device with broad-spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes. In human studies, Hemopurifier® therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs. We are now focused on advancing our Hemopurifier® as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens. Based on studies conducted by government and non-government research organizations, the Hemopurifier® is also a leading broad-spectrum treatment candidate to address bioterror and pandemic threats. For more information, please visit www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the ability to demonstrate ex vivo effectiveness of the Aethlon Hemopurifier® to remove immunosuppressive exosomes from the blood of advanced-stage cancer patients, future therapeutic trials in cancer patients, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the Hemopurifier's® ability to capture exosomes and the impact it may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
Jody Cain
Senior Vice President, Lippert/Heilshorn & Associates
310.691.7100
jcain@lhai.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page
Disclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) is a paid advertising client ($one thousand five hundred per month, $five thousand per month in 144 stock)
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page
Monday, October 17, 2011
Water/ Infrastructure Stock Alert: Pure Technologies Ltd. (TSX: PUR) Trading Up Over 16%
POINT ROBERTS - www.InvestorIdeas.com, a leader in sector stock research including water stocks and infrastructure stocks issues a trading alert for Pure Technologies Ltd.(TSX:PUR). The stock is trading at $3.45, up 0.49 (16.55%).
In September the Company announced it had been awarded new contracts in the United States for a combined value of approximately US$2 million. The services provided with these projects span the full range of Pure's inspection, condition assessment and engineering services for water and wastewater pipelines.
About Pure Technologies ( TSX: PUR)
Pure Technologies Ltd. is an international asset management technology and services company which has developed patented technologies for inspection, monitoring and management of critical infrastructure around the world. Pure's business model incorporates four distinct but complementary business streams:
Visit the company Profile on Investorideas.com
http://www.investorideas.com/CO/FRCN/
About Fireman's Contractors Inc. (OTCBB: FRCN)
Fireman's Contractors Inc. (OTCBB: FRCN) is a full service contractor providing superior service in parking lot maintenance and construction services. Our services include Road Improvements, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, ADA Compliance and other construction services which are delivered at a competitive price. Fireman's brings professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations. http://www.firemans-contractors.com/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Disclosure: Fireman's Contractors Inc. (OTCBB: FRCN) is a paid adverting construction stock on Investorideas.com and blogs (ten thousand for 3 months of advertising)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com was not compensated by PUR.TO
Source - Investorideas.com
800-665-0411
POINT ROBERTS - www.InvestorIdeas.com, a leader in sector stock research including water stocks and infrastructure stocks issues a trading alert for Pure Technologies Ltd.(TSX:PUR). The stock is trading at $3.45, up 0.49 (16.55%).
In September the Company announced it had been awarded new contracts in the United States for a combined value of approximately US$2 million. The services provided with these projects span the full range of Pure's inspection, condition assessment and engineering services for water and wastewater pipelines.
About Pure Technologies ( TSX: PUR)Pure Technologies Ltd. is an international asset management technology and services company which has developed patented technologies for inspection, monitoring and management of critical infrastructure around the world. Pure's business model incorporates four distinct but complementary business streams:
- Sales of proprietary monitoring technologies for pipelines, bridges and structures (SoundPrint®, SoundPrint® AFO);
- Recurring revenue from data analysis and site maintenance for these technologies, and from technology licensing;
- Premium technical services including inspection, leak detection and condition assessment (P-Wave®, SmartBall®, Sahara®, PipeDiver™, PureRobotics™);
- Specialized engineering services in areas related to asset management, primarily in the area of pipeline condition assessment for water and wastewater infrastructure (Openaka Corp., Price Brothers UK Ltd, and Jason Consultants).
Visit the company Profile on Investorideas.com
http://www.investorideas.com/CO/FRCN/
About Fireman's Contractors Inc. (OTCBB: FRCN)
Fireman's Contractors Inc. (OTCBB: FRCN) is a full service contractor providing superior service in parking lot maintenance and construction services. Our services include Road Improvements, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, ADA Compliance and other construction services which are delivered at a competitive price. Fireman's brings professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations. http://www.firemans-contractors.com/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Disclosure: Fireman's Contractors Inc. (OTCBB: FRCN) is a paid adverting construction stock on Investorideas.com and blogs (ten thousand for 3 months of advertising)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com was not compensated by PUR.TO
Source - Investorideas.com
800-665-0411
Infrastructure/ Construction Stock News: Fireman's Contractors (OTCBB:FRCN) Moves to New Texas Location to Facilitate Expansion and Growth
FORT WORTH, Texas - October 17, 2011 - Construction Stock News update: Fireman's Contractors Inc. (OTCBB: FRCN) (OTCQB:FRCN.OB) reports it has moved into their new corporate offices in Fort Worth , Texas . The relocation from North Richland Hills was spurred by continuous growth within the Company, including customer service, marketing, sales, operational personnel and will allow it to begin new efforts in franchise development. The Company is a full service contractor providing professional services for commercial and government clients in Road Improvements, Parking Lot Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, and Asphalt Maintenance and Repair.
"We are excited to complete renovations and move into a national corporate space where we can accommodate our growth, expand our services, cultivate our business relationships, develop our franchise system, and enable current and future employees to work efficiently under one roof," stated, Renee Gilmore, CEO of Fireman's Contractors.
New Headquarters: Fireman's Contractors, Inc.
2406 Gravel Drive
Fort Worth , TX 76118
Fireman's Contractors Inc. (OTCBB:FRCN.OB) is a full service contractor providing professional services for commercial and government clients. Services include Road Improvements, Parking Lot Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Fireman's Contractors has completed its FDD requirements with the Federal Trade Commission and has developed franchise territories across the U.S. The Company's goal is to develop 25 new franchise locations in the next 24 to 48 months. Fireman's brings a professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations.
Founded by a Firefighter, Fireman's Contractors -- Contractors You Can Trust (R)
To learn more about Fireman's Contractors, please visit our website:
http://www.Firemans-Contractors.com
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
Contact:
Fireman's Contractors Inc.
2406 Gravel Road
Fort Worth , TX 76118
Phone: 800-475-1479
info@FiremansContractors.com
http://www.Firemans-Contractors.com
Investor Relations Contact:John Pentony, IR Affiliates
Contact: john@iraffiliates.com
Tel: 469.252.3031
Public Relations Contact: Danielle O'Neal
Contact: PR@FiremansContractors.com
Tel: 800-475-1479
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Twitter.com
http://twitter.com/#!/firemansco
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors
FORT WORTH, Texas - October 17, 2011 - Construction Stock News update: Fireman's Contractors Inc. (OTCBB: FRCN) (OTCQB:FRCN.OB) reports it has moved into their new corporate offices in Fort Worth , Texas . The relocation from North Richland Hills was spurred by continuous growth within the Company, including customer service, marketing, sales, operational personnel and will allow it to begin new efforts in franchise development. The Company is a full service contractor providing professional services for commercial and government clients in Road Improvements, Parking Lot Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, and Asphalt Maintenance and Repair.
"We are excited to complete renovations and move into a national corporate space where we can accommodate our growth, expand our services, cultivate our business relationships, develop our franchise system, and enable current and future employees to work efficiently under one roof," stated, Renee Gilmore, CEO of Fireman's Contractors.
New Headquarters: Fireman's Contractors, Inc.
2406 Gravel Drive
Fort Worth , TX 76118
Fireman's Contractors Inc. (OTCBB:FRCN.OB) is a full service contractor providing professional services for commercial and government clients. Services include Road Improvements, Parking Lot Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Fireman's Contractors has completed its FDD requirements with the Federal Trade Commission and has developed franchise territories across the U.S. The Company's goal is to develop 25 new franchise locations in the next 24 to 48 months. Fireman's brings a professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations.
Founded by a Firefighter, Fireman's Contractors -- Contractors You Can Trust (R)
To learn more about Fireman's Contractors, please visit our website:
http://www.Firemans-Contractors.com
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
Contact:
Fireman's Contractors Inc.
2406 Gravel Road
Fort Worth , TX 76118
Phone: 800-475-1479
info@FiremansContractors.com
http://www.Firemans-Contractors.com
Investor Relations Contact:John Pentony, IR Affiliates
Contact: john@iraffiliates.com
Tel: 469.252.3031
Public Relations Contact: Danielle O'Neal
Contact: PR@FiremansContractors.com
Tel: 800-475-1479
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Twitter.com
http://twitter.com/#!/firemansco
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors
Fireman's Contractors Inc. (OTCBB:FRCN), (OTCQB:FRCN.OB) is a featured construction stock on Investorideas.com
Visit the company profile to learn more: http://www.investorideas.com/CO/FRCN/
Disclaimer/ Disclosure: FRCN has compensated Investorideas.com ten thousand for three months of advertising. All info published is sourced from public files or the Company. This is not a solicitation go buy or sell securities.
Biotech Leads Friday's NASDAQ Winners: GTXI, ACHN, SZYM, GNOM;
POINT ROBERTS - October 17, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Friday October 14th. Nasdaq closed higher by +47.61 (+1.82%) at 2667.85.
GTx, Inc. (NASDAQ:GTXI) was the top percentage gainer for the session closing higher 0.68 (20.36%) to $4.02 after analyst at Rodman & Renshaw started coverage on the stock an "outperform" rating and a $7.00 price target on the stock.
The stock is continuing its gains in early morning trading Monday.
The Company is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) surged 0.89 (18.05%) to close at $5.82 after it announced the nomination of an additional clinical candidate for the treatment of the hepatitis C virus (HCV) from its NS5A inhibitor program. The candidate, ACH-3102, is a second generation NS5A inhibitor that in preclinical studies has demonstrated potent pan-genotypic activity against HCV genotypes 1 - 6, including excellent activity against both the genotype 1a subtype and known mutant variants of genotype 1 HCV.
Solazyme Inc (NASDAQ:SZYM) closed with an impressive gain of 1.50 (17.99%) to end the day at $9.84, bouncing back from its recent low. The stock has a 52-week range of $7.68-$27.47. The company has market capitalization of $587.15 million.
Complete Genomics, Inc. (NASDAQ:GNOM) moved higher by 0.78 (16.53%) to $5.50, bouncing back from its 52-week low made on Oct 13, 2011. The stock has a 52-week range of $4.70-$18.55. The company has market capitalization of $181.99 million.
About www.InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Ideas Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online plus stock alerts and investing ideas
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join monthly or annually: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
POINT ROBERTS - October 17, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Friday October 14th. Nasdaq closed higher by +47.61 (+1.82%) at 2667.85.
GTx, Inc. (NASDAQ:GTXI) was the top percentage gainer for the session closing higher 0.68 (20.36%) to $4.02 after analyst at Rodman & Renshaw started coverage on the stock an "outperform" rating and a $7.00 price target on the stock.
The stock is continuing its gains in early morning trading Monday.
The Company is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) surged 0.89 (18.05%) to close at $5.82 after it announced the nomination of an additional clinical candidate for the treatment of the hepatitis C virus (HCV) from its NS5A inhibitor program. The candidate, ACH-3102, is a second generation NS5A inhibitor that in preclinical studies has demonstrated potent pan-genotypic activity against HCV genotypes 1 - 6, including excellent activity against both the genotype 1a subtype and known mutant variants of genotype 1 HCV.
Solazyme Inc (NASDAQ:SZYM) closed with an impressive gain of 1.50 (17.99%) to end the day at $9.84, bouncing back from its recent low. The stock has a 52-week range of $7.68-$27.47. The company has market capitalization of $587.15 million.
Complete Genomics, Inc. (NASDAQ:GNOM) moved higher by 0.78 (16.53%) to $5.50, bouncing back from its 52-week low made on Oct 13, 2011. The stock has a 52-week range of $4.70-$18.55. The company has market capitalization of $181.99 million.
About www.InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Ideas Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online plus stock alerts and investing ideas
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join monthly or annually: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
Biotech and Pharma stocks News; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) To Present at BioCentury and BIO Healthcare Conferences
LINCOLNSHIRE, Ill. - October 17, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that Stephen M. Simes, BioSante�s president & CEO will present at two healthcare conferences in October. Mr. Simes will speak at the BioCentury NewsMakers in the Biotech Industry on Friday, October 21 at 11:30 am EDT in New York and at the BIO Investor Forum on Tuesday, October 25 at 3:30 pm PDT in San Francisco.
BioSante will provide a company overview at each conference, as well as an update on the LibiGel� (testosterone gel) Phase III clinical development program and planned new drug application (NDA) submission.
A live audio webcast of remarks by Mr. Simes, at the BioCentury conference may be accessed at http://www.corporate-ir.net/ireye/ conflobby.zhtml?ticker= BPAX&item_id=4209619. A live audio webcast of remarks by Mr. Simes, at BIO Investor Forum may be accessed at http://www.veracast.com/webcasts/ bio/ investorforum2011/16113461.cfm. Both webcasts will be archived for 90 days.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
Harris D. McKinney, Inc.
Alan Zachary, 312-506-5220
azachary@harrisdmckinney.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com
LINCOLNSHIRE, Ill. - October 17, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that Stephen M. Simes, BioSante�s president & CEO will present at two healthcare conferences in October. Mr. Simes will speak at the BioCentury NewsMakers in the Biotech Industry on Friday, October 21 at 11:30 am EDT in New York and at the BIO Investor Forum on Tuesday, October 25 at 3:30 pm PDT in San Francisco.
BioSante will provide a company overview at each conference, as well as an update on the LibiGel� (testosterone gel) Phase III clinical development program and planned new drug application (NDA) submission.
A live audio webcast of remarks by Mr. Simes, at the BioCentury conference may be accessed at http://www.corporate-ir.net/ireye/ conflobby.zhtml?ticker= BPAX&item_id=4209619. A live audio webcast of remarks by Mr. Simes, at BIO Investor Forum may be accessed at http://www.veracast.com/webcasts/ bio/ investorforum2011/16113461.cfm. Both webcasts will be archived for 90 days.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
Harris D. McKinney, Inc.
Alan Zachary, 312-506-5220
azachary@harrisdmckinney.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com
Friday, October 14, 2011
Nanotech Stock to Watch; Nanosphere, Inc. (NasdaqGM: NSPH) Trading up over 8%
POINT ROBERTS, October 14, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for nanotech stock, Nanosphere, Inc.(NasdaqGM: NSPH), trading at $1.12, up 0.09 (8.25%) 3:17PM EDT.
The most recent news from the Company, September 19th, stated "Nanosphere's (Nasdaq:NSPH) Verigene BC-GP test, based on the company's proprietary array-based nanoparticle technology, demonstrated 100% sensitivity and specificity for detection of the drug-resistant bacteria MRSA and VRE, and an overall sensitivity of 98.4% for a broad panel of bacterial targets, according to an initial study."
Nanosphere is using the power of nanotechnology to create innovative molecular diagnostics for the medical field. The Verigene(R) System is an easy-to-use cartridge-based platform that enables rapid, cost-effective, multiplexed testing in a near-patient setting. Current and forthcoming products include clinical diagnostics in the areas of infectious disease, pharmacogenetics, cardiology, and human genetics.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Learn More about Investorideas.com Nanotech showcase stocks
http://www.investorideas.com/Nanotechnology/
Get the global stock directory of publicly traded nanotech stocks
http://www.investorideas.com/Nanotechnology/ Stocks_List.asp
Sign up for the free investor news and hot stock alerts http://www.investorideas.com/ Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Investorideas.com was not compensated by Nanosphere for this article
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411
POINT ROBERTS, October 14, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for nanotech stock, Nanosphere, Inc.(NasdaqGM: NSPH), trading at $1.12, up 0.09 (8.25%) 3:17PM EDT.
The most recent news from the Company, September 19th, stated "Nanosphere's (Nasdaq:NSPH) Verigene BC-GP test, based on the company's proprietary array-based nanoparticle technology, demonstrated 100% sensitivity and specificity for detection of the drug-resistant bacteria MRSA and VRE, and an overall sensitivity of 98.4% for a broad panel of bacterial targets, according to an initial study."
Nanosphere is using the power of nanotechnology to create innovative molecular diagnostics for the medical field. The Verigene(R) System is an easy-to-use cartridge-based platform that enables rapid, cost-effective, multiplexed testing in a near-patient setting. Current and forthcoming products include clinical diagnostics in the areas of infectious disease, pharmacogenetics, cardiology, and human genetics.About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Learn More about Investorideas.com Nanotech showcase stocks
http://www.investorideas.com/Nanotechnology/
Get the global stock directory of publicly traded nanotech stocks
http://www.investorideas.com/Nanotechnology/ Stocks_List.asp
Sign up for the free investor news and hot stock alerts http://www.investorideas.com/ Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Investorideas.com was not compensated by Nanosphere for this article
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)